SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-20-000586
Filing Date
2020-07-13
Accepted
2020-07-13 17:24:06
Documents
10
Period of Report
2020-07-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm 8-K 30013
2 AMENDMENT AND RESTATEMENT AGREEMENT, DATED AS OF JULY 9, 2020, BY AND AMONG CURE ex10x1.htm EX-10.1 78536
3 FINANCE CONTRACT, AS AMENDED AND RESTATED PURSUANT TO THE FIRST AMENDMENT AND RE ex10x2.htm EX-10.2 436564
4 GUARANTEE AND INDEMNITY AGREEMENT, DATED AS OF JULY 9, 2020, BY AND BETWEEN EURO ex10x3.htm EX-10.3 159853
5 GUARANTEE AND INDEMNITY AGREEMENT, DATED AS OF JULY 9, 2020, BY AND BETWEEN EURO ex10x4.htm EX-10.4 154356
6 PRESS RELEASE ex99x1.htm EX-99.1 12559
7 GRAPHIC image_001.jpg GRAPHIC 5907
8 GRAPHIC image_001.gif GRAPHIC 2629
9 GRAPHIC image_002.gif GRAPHIC 3066
10 GRAPHIC opgen_logov1.jpg GRAPHIC 5381
  Complete submission text file 0001079973-20-000586.txt   897140
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 201025843
SIC: 8071 Services-Medical Laboratories